Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 281 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/30/19
End: 01/30/23
Due: 01/30/24
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 07/30/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 07/09/18
End: 07/09/23
Due: 07/09/24
Phase: N/A
Priority: Normal
Start: 04/08/16
End: 05/30/17
Due: 05/30/18
Phase: N/A
Priority: Normal
Start: 05/25/20
End: 08/25/25
Due: 08/25/26
Phase: N/A
Priority: Normal
Start: 09/21/21
End: 06/15/26
Due: 06/15/27
Phase: N/A
Priority: Normal
Start: 01/02/15
End: 02/20/20
Due: 02/20/21
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 12/18/24
Due: 12/18/25
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 03/01/20
Due: 03/01/21
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 05/08/17
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 04/27/15
End: 03/28/18
Due: 03/28/19
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 11/30/13
Due: 11/30/14
Induction of Sustained Unresponsiveness to Sesame Using High- and Low-dose Sesame Oral Immunotherapy
Phase: N/A
Priority: Normal
Start: 03/24/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 02/01/19
End: 02/01/23
Due: 02/01/24
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 05/30/27
Due: 05/30/28
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 06/04/19
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 12/06/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 09/30/19
Due: 09/30/20
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 12/31/24
Due: 12/31/25